康臣药业(01681)10月17日斥资477.91万港元回购31.7万股

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Group 1: Company Actions - 康臣药业 plans to repurchase 317,000 shares at a total cost of HKD 4.7791 million [1] - The buyback price per share ranges from HKD 14.97 to HKD 15.20 [1]